Sort
48,018 grants matching “immunotherapy”
Specific Adoptive Immunotherapy of Leukemia
$480,639Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Focal segmental glomerulosclerosis: Treatment
$480,623Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$480,623James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Project 1: Spatial imaging of whole tumor genomics to understand glioblastoma formation and evolution
$480,584Joseph F Costello · University Of California, San Francisco · P01 · FY2024 · CA
Project 1: Spatial imaging of whole tumor genomics to understand glioblastoma formation and evolution
$480,584Joseph F Costello · University Of California, San Francisco · P01 · FY2025 · CA
Spatiotemporal regulation of collective cell behaviors in Drosophila
$480,497Denise J. Montell · University Of California Santa Barbara · R01 · FY2025 · GM
Clinical Investigation of Epigenetic Therapy
$480,497John C Byrd · Ohio State University · P01 · FY2008 · CA
Spatiotemporal regulation of collective cell behaviors in Drosophila
$480,497Denise J. Montell · University Of California Santa Barbara · R01 · FY2023 · GM
Spatiotemporal regulation of collective cell behaviors in Drosophila
$480,493Denise J. Montell · University Of California Santa Barbara · R01 · FY2024 · GM
Posttranscriptional control of gene expression
$480,490Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
ANTIVIRAL &ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
$480,478Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · AA
Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma.
$480,412Alexander H. Stegh · Washington University · R01 · FY2025 · NS
Vascular regulation of fatty acid transport in metastatic tumor outgrowth
$480,397Jin Chen · Vanderbilt University Medical Center · R01 · FY2024 · CA
Repurposing TRM for tumor immunotherapy
$480,356David Masopust · University Of Minnesota · R01 · FY2022 · CA
Autophagy proteins in the immune response to Mycobacterium tuberculosis infection
$480,356Christina Leigh Stallings · Washington University · R01 · FY2021 · AI
Repurposing TRM for tumor immunotherapy
$480,356David Masopust · University Of Minnesota · R01 · FY2023 · CA
Breast Cancer Treatment with Antibody Targeted T Cells
$480,343Lawrence G Lum · Wayne State University · R01 · FY2011 · CA
Intelligent treatment planning for cancer radiotherapy
$480,330Steve Bin Jiang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Intelligent treatment planning for cancer radiotherapy
$480,330Steve Bin Jiang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Molecular Immunology and Tumor Biology
$480,327David Michael Langenau · Massachusetts General Hospital · T32 · FY2021 · CA
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer
$480,259Triparna Sen · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma
$480,254Tzu-Yin Lin · Theranostec, Inc. · R44 · FY2021 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$480,247Iwei Yeh · University Of California, San Francisco · R37 · FY2024 · CA
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$480,188Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2025 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$480,181James Hodge · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA